Spinocerebellar Ataxia type 1 (SCA1) and Huntington's disease (HD) are two polyglutamine disorders caused by expansion of a CAG repeat within the coding regions of the Ataxin-1 and Huntingtin proteins, respectively. While protein folding and turnover have been implicated in polyglutamine disorders in general, many clinical and pathological differences suggest that there are also disease-specific mechanisms. Taking advantage of a collection of genetic modifiers of expanded Ataxin-1-induced neurotoxicity, we performed a comparative analysis in Drosophila models of the two diseases. We show that while some modifier genes function similarly in SCA1 and HD Drosophila models, others have model-specific effects. Surprisingly, certain modifier genes modify SCA1 and HD models in opposite directions, i.e. they behave as suppressors in one case and enhancers in the other. Furthermore, we find that modulation of toxicity does not correlate with alterations in the formation of neuronal intranuclear inclusions. Our results point to potential common therapeutic targets in novel pathways, and to genes and pathways responsible for differences between Ataxin-1 and Huntingtin-induced neurodegeneration.
INTRODUCTION
Several dominantly inherited human neurodegenerative diseases result from the expansion of a translated tract of consecutive CAG trinucleotide repeats. Because CAG encodes for glutamine, these disorders are referred as polyglutamine diseases. To date, this group includes Kennedy's disease or Spinal-Bulbar Muscular Atrophy (SBMA), Huntington's disease (HD), Dentatorubral-Pallidoluysian Atrophy (DRPLA) and several distinct Spinocerebellar Ataxias (SCA1, SCA2, SCA3/Machado -Joseph disease, SCA6, SCA7 and SCA17). The normal function of many of the genes causing these disorders remains unclear and the corresponding proteins have no sequence similarity with each other except for the polyglutamine tract itself. Although the disease-causing proteins are widely expressed in the CNS, these disorders are characterized by loss of specific neuronal populations, resulting in characteristic patterns of neurodegeneration and clinical manifestations. In all cases, the disease only occurs once the glutamine expansion surpasses a certain threshold. The clinical symptoms usually manifest around mid-life, and become progressively worse within the next two decades of life. Furthermore, longer repeats lead to earlier age of onset with very long expansions causing juvenile cases (reviewed in 1).
It has been proposed that these disorders are caused by gain of toxic function mechanisms. In agreement with this idea, mice models expressing the expanded mutant protein show cell loss and characteristic neurodegenerative phenotypes (2, 3) . Therefore, even though in some cases the † Present address: Department of Neurology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA There is also abundant evidence that protein context is important for polyglutamine toxicity. For example, posttranscriptional modifications outside of the polyglutamine tract are critical in determining the clinical and pathological effects of the corresponding proteins (reviewed in 2, 3) .
Polyglutamine diseases share a number of common features including progressive neuronal degeneration and formation of protein aggregates. These aggregates contain the mutant polyglutamine protein and other proteins such as ubiquitin, chaperones and proteasome subunits. The neuronal aggregates can be mainly nuclear [nuclear inclusions (NIs); SCA1, SCA7 and SCA17], cytoplasmic (SCA6) or present in both cytoplasm and nucleus as in HD, DRPLA, SBMA, SCA2 and SCA3 (3, 5, 6) . The role of NIs in pathogenesis has been a matter of much debate. At first, the predominant idea was that NIs are pathogenic as they may sequester essential proteins and interfere with their normal function. Later evidence led to the alternative view that NIs are not the main drivers of toxicity. NIs may be in fact protective by sequestering toxic oligomeric forms of the mutant protein, and preventing deleterious interactions between these oligomers and other cellular proteins (2, 3, 6, 7) .
Certain disease mechanisms may be common to all polyglutamine diseases. Protein misfolding, protein turnover, transcriptional dysregulation and apoptosis have been implicated in many of these disorders (reviewed in 2,3,8 -10). However, many important specific questions remain unanswered; e.g. Are the same genes and pathways involved in transcriptional alterations in different polyglutamine diseases? Other mechanisms, such as RNA processing, axonal transport, synaptic transmission, calcium homeostasis, mitochondrial dysfunction or endoplasmic reticulum impairment have been implicated in the pathogenesis of one or more of these disorders (3, (11) (12) (13) . Are some of these mechanisms also common to many polyglutamine diseases? Comparative studies are required to answer these questions, and to identify common and disease-specific genetic pathways implicated in disease progression. These studies will also facilitate the development of effective therapies by identifying potential therapeutic targets.
SCA1 and HD are autosomal dominant diseases caused by expansion of a polyglutamine tract on the N-terminal region of the Ataxin-1 and Huntingtin (Htt) proteins, respectively. SCA1 is characterized by loss of coordination, impaired balance, motor and cognitive decline. These clinical features are associated with degeneration of cerebellar Purkinje cells, spinocerebellar tracts and, to a lesser extent, brain stem nuclei (14) . In HD, clinical manifestations include involuntary movements (chorea), cognitive decline and psychiatric disturbances that lead to progressive dementia. These characteristic symptoms result mainly from degeneration of striatal neurons but also from degeneration of cortex neurons (4, 15) .
Comparative analysis of genetic modifiers of disease using animal models is a powerful approach to identify common and distinct mechanisms of pathogenesis exerted by different polyglutamine proteins. Drosophila is well suited for this type of analysis because of the surprising similarity of its genome and the human genome, the ability to manipulate up or down the activity of most of its genes and the fast pace of experimentation (16) . To date, only a small number of modifier genes have been compared in fly models of neurodegenerative diseases (17) . Here we take advantage of Drosophila models of HD and SCA1 to compare genetic modifiers and mechanisms of pathogenesis of Ataxin-1 and Huntingtin toxicity.
We find modifier genes that are common to the SCA1 and HD models that function in protein folding/degradation, apoptosis and transcriptional regulation as well as in RNA processing and signaling. Other modifier genes have disease model specific effects. Of these, a group modulates disease progression in both SCA1 and HD Drosophila models, but in opposite ways. The observed phenotype modifications are not cell-type specific since we obtained similar results using both eye and neuro-behavioral assays.
RESULTS

Degenerative phenotypes and NIs caused by targeted expression of either SCA1
82Q or Htt 128Q transgenes in Drosophila can be used for comparative analysis of modifier genes
The directed over expression (OE) of the transgene of interest was achieved by using the GMR-GAL4 driver, which directs expression to photoreceptor neurons and surrounding support eye cells. OE of the human Ataxin-1 protein containing a polyglutamine tract of 82 glutamines (Ataxin-1 82Q , Fig. 1A , top) in the eye causes an external eye phenotype consisting of ommatidial disorganization and interommatidial bristle loss that can be used to screen for genetic modifiers [ Fig. 1C and B (control), (18) ]. These flies expressing the SCA1 82Q transgene also display a retinal phenotype, characterized by a decrease in the length of the retina, tissue loss and shortened and abnormal photoreceptor neurons [ Fig. 1F and E (control)].
We have also generated transgenic flies over expressing the N-terminal portion of the Huntingtin protein (amino acids 1-336) including an expanded tract of 128 glutamine repeats (Htt 128Q , Fig. 1A , bottom). Unlike flies expressing Ataxin-1 82Q that display a severe rough external eye phenotype, the N-terminal HD model flies show mild ommatidial disorganization and bristle loss phenotypes (Fig. 1D) . However, longitudinal sections show severe disorganization, tissue loss and vacuolization in the retina of these flies (Fig. 1G ). This effect is even more dramatic in aged flies (Fig. 1H) , demonstrating that the degenerative phenotype is progressive.
Like in SCA1 82Q -expressing flies, in the HD model we observe formation of neuronal NIs, one of the hallmarks of both diseases [ Fig. 1I-K during the aging process of the fly (data not shown) in agreement with the progressiveness of the model. Using the eye phenotypes described above as a primary assay, we investigated the effects of a collection of candidate modifier genes on the SCA1 and HD models. This collection mainly includes modifier genes previously identified in a forward genetic screen using the SCA1 model (18) . We found three different categories of modifiers: genes that modify SCA1
82Q and Htt 128Q -induced phenotypes similarly, genes that appear to modify only one of the models, and genes that modify the two disease models in opposite ways. , that is, 6 days old. In I-K, flies are 3 days old. Scale bar in SEM pictures is equivalent to 100 mM (10 mM in the magnification insets) and equivalent to 10 mM in the retinal paraffin sections and the immunofluorescence staining.
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128Q -induced phenotypes similarly
The genes in this group are listed in Table 1 and representative examples are shown in Figure 2 . They include genes encoding signal transduction or RNA-binding proteins that were not previously known to modulate the toxicity of different polyglutamine proteins. Interestingly, this group also includes specific transcription factors that modulate the toxicity of Ataxin-1 82Q and Htt 128Q in a similar manner. skuld (skd) is an example of a transcription factor whose partial LOF enhances of the toxicity of both Ataxin-1 82Q and Htt
128Q
. As shown in Figure 2B and J, one functional copy of skd (skd LOF ) induces a decrease in the length of the retina and promotes increased disorganization and tissue loss in the eyes of both the Ataxin-1 82Q and Htt 128Q -expressing flies, but does not have a phenotype on its own (Supplementary Fig. S1L ). Controls are shown in Figures 2A and 1F for Ataxin-1 82Q and 2I for Htt 128Q , respectively. pumilio (pum) and cpo, encode RNA-binding proteins and also modify SCA1 and HD model phenotypes similarly. OE of pum or cpo enhances both SCA1 82Q [ Fig. 2C ; (18) ] and Htt
-induced eye phenotypes (Fig. 2K , data not shown), but does not show a phenotype by itself ( Supplementary  Fig. S1F ). Furthermore, loss of one functional copy of pum increases the thickness of the retina both in the SCA1 and HD Drosophila models, decreases cell loss ( Fig. 2D and L, respectively), and does not display an eye phenotype alone ( Supplementary Fig. S1N ). Since they are RNA-binding proteins, we monitored if pum or cpo alleles would modify the Htt 128Q or SCA1 82Q mRNA levels, and found no difference with controls (Supplementary Fig. 2A and B) . We also monitored the levels of Htt 128Q and Ataxin-1 82Q proteins with these modifiers in eye imaginal discs. Neither pum nor cpo had an effect on Htt 128Q levels. However, OE of pum did cause an increase in the Ataxin-1 82Q levels, whereas its LOF or OE of cpo had no effect (Supplementary Fig. S2C ).
14-3-31, encodes a protein involved in signal transduction and its OE enhances both SCA1 82Q and Htt 128Q -induced eye phenotypes ( Fig. 2E and M, respectively) . Note the drastic reduction in the length of the retina, accompanied with tissue loss. In contrast, 14-3-31 LOF suppresses both SCA1 and HD model phenotypes as it promotes an increase in length of the retina and improves retinal integrity [ Fig. 2F and N, respectively; (19) ]. Modulating the expression levels of 14-3-31 does not cause a phenotype in control eyes (Supplementary Fig. S1G and O).
We have also tested the effect of an anti-apoptotic protein, Drosophila inhibitor of apoptosis (DIAP1) or thread (th), in the two models. Confirming previous results (17), we find that OE of DIAP1 strongly suppresses the SCA1 82Q -induced eye phenotype (Fig. 2G) . We also found that DIAP1 OE suppresses the Htt 128Q eye phenotypes ( Fig. 2O ) and does not have a phenotype on its own ( Supplementary Fig. S1H ). In contrast, SCA1 82Q or Htt 128Q -expressing flies that also carry a LOF allele of DIAP1 (th Genes that modify only Ataxin-1 82Q toxicity
This group includes modifiers of SCA1
82Q
-induced toxicity previously reported (18) , as well as new Ataxin 82Q modifiers reported here. They include both enhancers; i.e. heat-shock RNA v (Hsrv), Sc2, Rpd3, C-terminal-binding protein (dCtBP) and GstS1) as well as suppressors; i.e. pasilla (ps), and Nucleoporin-44A (Nup44A) of Ataxin 82Q toxicity. In the context of the HD model, however, we were unable to detect modification of the eye phenotype by these genes ( Table 2 , data not shown).
Genes that modify SCA1
82Q -and Htt
128Q -induced phenotypes in opposite ways
Of all the genes tested, this group is perhaps the most intriguing. In Table 3 , we list the genes that induce a clear modification of both SCA1 82Q and Htt
128Q
-induced phenotypes, but in opposite directions. Therefore, these modifiers are good candidates to uncover specific mechanisms of Ataxin-1 82Q and Htt 128Q toxicity. Representative examples of this interesting class of modifiers are described below in more detail. 82Q transgenic flies over expressing pum show a more severe eye phenotype than controls. These flies have a more disorganized retina with some tissue loss (compare with the control in A). In Htt 128Q flies, pum OE clearly increases the amount of tissue loss (K). Decreased levels of pum, on the other hand, are responsible for an increase in the length and organization of the retina both in SCA1 and HD models (D and L, respectively). In the HD model (L) note also that pum LOF induces a decrease in tissue loss compared with control in (I). OE of 14-3-31 is a strong enhancer of both SCA1 82Q and Htt
eye phenotypes (E and M). Note the dramatic decrease in the length of the retina that 14-3-31 OE causes in both models, as well as an increase in tissue loss in the SCA1 model (E). (F and N) Decreased levels of 14-3-31, on the other side, suppress both SCA1 82Q and Htt 128Q eye phenotypes. Note improved organization of the retina as well as decrease in tissue loss. (G) SCA1 82Q flies that also over express DIAP1 display a retinal phenotype very similar to wild-type flies (compare with 1E). Note the improvement of the retinal organization as well as length. The improvement is also evident in Htt 128Q flies over expressing DIAP1 (O). Decreased levels of DIAP1 also induce a modification of the SCA1 82Q and Htt 128Q eye phenotypes (H and P, respectively). Note the decrease in the length of the retina, along with increased tissue loss. skd LOF , pum (OE and LOF), 14-3-31 (OE and LOF) and DIAP1 (OE and LOF) do not display an eye phenotype by themselves ( Supplementary Fig. S1 ). Genotypes:
82Q transgenic flies shown are 1 day old and all Htt 128Q flies are 6 days old. All flies were raised at 258C. Scale bar is equivalent to 10 mM.
Akt1. Ataxin-1 and Huntingtin have been reported as substrates of Akt1, a serine/threonine kinase involved in numerous cell survival pathways (19, 20) . OE of Akt1 enhances SCA1 82Q -induced eye and retinal degeneration but suppresses degeneration caused by OE of Htt 128Q , and does not cause an eye phenotype by itself ( Fig. 3; Supplementary Fig. S1B ). Externally, OE of Akt1 is responsible for an increased disorganization and degeneration of the ommatidia of Ataxin-1 82Q flies ( Fig. 3A and B) . Internally, Akt1 OE increases the disorganization of photoreceptors in the retina of Ataxin-1 82Q animals and also causes tissue loss ( Fig. 3E and F) . Conversely, in the HD model, OE of Akt1 increases the thickness of the retina and improves tissue integrity when compared with flies expressing Htt 128Q alone ( Fig. 3H and I ). Furthermore, reducing the endogenous levels of Akt1 with one copy of a LOF allele ameliorates the SCA1 82Q -induced eye phenotype. These flies have improved organization of the ommatidia [ Fig. 3C and D(control)] and increased length of the retina ( Fig. 3E and G 128Q protein levels (in eye imaginal discs), and found no significant effect of mub in larvae ( Supplementary Fig. S2 ).
Vibrator (vib). vib encodes a Drosophila orthologue of mammalian proteins implicated in lipid transport. vib is involved in phosphatidylinositol transfer (21) , it plays a role in actin-based processes and signal transduction (22) , and a recent report relates its function to cytokinesis (23) .
In the SCA1 Drosophila model, increased levels of vib suppress the Ataxin-1 82Q eye phenotype ( 82Q alone ( Fig. 5C and D) . In the HD Drosophila model, vib OE is an enhancer of the eye phenotype, severely reducing to almost 50% the length of the retina of Htt 128Q flies, but does not display an eye phenotype on its own [ Fig. 5F and E (control); Supplementary Fig. S1D ].
Because no LOF alleles of vib were available at the time of this study, only OE alleles were tested. However, even though only one allele is shown, two distinct vib OE alleles were analyzed, and the results obtained for both alleles in the two fly models are identical (data not shown).
CG14438. CG14438 encodes a protein with 21 zinc finger domains whose function is unknown. OE of CG14438 is one of the strongest suppressors of the Ataxin-1 82Q eye phenotype we have recovered. At the external level, it improves the organization of the ommatidia [ Fig. 6B and A (control) Supplementary Fig. S1M ). Externally the ommatidia and Fig. 6H and I; Supplementary Fig. S1E ). The length of the retina of Htt
128Q /CG14438
OE flies is dramatically reduced and there is also an increase in its disorganization in comparison to flies expressing Htt 128Q alone ( Fig. 6I ; compare with Fig. 6H) . Conversely, the LOF allele causes an increase in length of the retina, as well as a decrease in retinal tissue loss when compared with control flies (Fig. 6J and H) .
Validation of the Ataxin-1 82Q and Htt 128Q eye modifier genes in a motor performance assay
To investigate whether the genetic interactions described above in the eye are also valid in the CNS, we carried out a motor performance test that measures the climbing ability of flies as function of age. We used the nervana-GAL4 driver, which directs expression of the transgenes of interest to the CNS, and measured the number of flies that are able to climb above a 5 cm line marked in the vials in 18 s. Using this assay we tested specific genes from Table 3 that do not display a phenotype by themselves when the nervana-GAL4 driver is used. Flies used for SEM analysis were raised either at 258C (A and B) or 278C (C and D). All flies for paraffin vertical sections were raised at 258C (E-K). Scale bar in SEM pictures is equivalent to 100 mM (10 mM in the magnification insets) and equivalent to 10 mM in the retinal paraffin sections.
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Wild type or other control strains perform well in the climbing assay until late in life ( Fig. 7A and B) . In contrast, SCA1 82Q and Htt
128Q
-expressing flies perform well only as young adults, becoming progressively more impaired as they age (Fig. 7A and B, respectively) . In SCA1
82Q
-expressing flies, climbing performance is impaired by day 20-21 (when only 50% of the flies are still able to climb) in comparison to control flies that only start to lose their ability to climb by day 32 (Fig. 7A) . Similarly, in the HD model, by day 24, the climbing performance is impaired (only 50% of the flies are still able to climb), whereas in the control, at this age, 70% of the flies are still able to climb (Fig. 7B) .
As shown in Figure 7A , OE of the Ataxin-1 82Q suppressors mub and vib improves the climbing performance of the SCA1 82Q -expressing flies. Flies co-expressing mutant Ataxin-1 and either mub or vib are able to climb normally until a later age. Note that while %50% of the flies expressing SCA1 82Q fail to climb by day 21, in flies that over express either mub or vib in addition to SCA1
82Q it takes between 28 and 25 days, respectively, to observe a similar motor impairment.
The results obtained with the climbing assay for the HD model also mimic the results obtained in the eye: OE of mub and vib worsens the Htt 128Q -induced motor impairments (Fig. 7B) . The climbing performance of Htt 128Q /mub OE or . (J) w; GMR-GAL4/þ; Htt 128Q [M64]/mub 04093 . All SCA1 82Q transgenic flies shown are 1 day old and all flies expressing mutant Htt are 6 days old. Flies used for SEM analysis were raised at 278C (A and B) or 258C (C and D). All flies for paraffin vertical sections were raised at 258C (E -J). Scale bar in SEM pictures is equivalent to 100 mM (10 mM in the magnification insets) and equivalent to 10 mM in the retinal paraffin sections.
Htt
128Q /vib OE flies is impaired by day 19 and 21, respectively, where 50% of the flies fail to climb. In comparison, by this age, %80% of flies that express Htt 128Q alone are still able to climb, and only by day 24 there is a decrease to 50%, in the percentage of flies able to climb. Note that mub OE and vib OE do not have a climbing phenotype on their own ( Fig. 7A and B) .
Therefore, the observation that certain modifier genes have opposite effects on Htt 128Q and SCA1 82Q -induced toxicity is not only valid in the eye, but it is also true when using a motor behavior test based on expression of these proteins in the CNS.
Alteration of Ataxin-1 82Q and Htt 128q protein aggregation in NIs does not correlate with suppression or enhancement of neurotoxicity
We investigated whether genes modifying the toxicity of Ataxin-1 82Q and Htt 128Q also modify their aggregation into NIs. With this goal in mind, we generated flies that over express the SCA1 82Q and Htt 128Q transgenes under the control of OK107-GAL4, a driver directing expression to welldefined subset of CNS neurons ( Fig. 8A and B) . Figure 8C and D shows the quantification of neurons that contain Ataxin-1 or Huntingtin NIs respectively. Note that, with this driver and in the specific experimental conditions used, we observe that 43% of the SCA1 82Q -expressing neurons have NIs, whereas 13% of the neurons that express Htt 128Q have NIs. Figure 8C shows that OE of the Ataxin-1 82Q suppressor CG14438 leads to an increase in the percentage of neurons containing Ataxin-1 82Q NIs, when compared with appropriate SCA1 82Q controls that over express LacZ. Conversely, flies that express SCA1 82Q and carry the CG14438 LOF allele have fewer neurons with Ataxin-1 82Q NIs than the corresponding controls. In addition, OE of CG14438 also correlates with increased Ataxin-1 82Q levels detected in eye imaginal discs ( Supplementary Fig. S2C ). On the other hand, OE of vib or the E3 ligase CHIP, also suppressors of Ataxin-1 82Q toxicity [this report and (24)], decrease the percentage of neurons that contain NIs. This observation is valid for both vib alleles tested (Fig. 8C, data not shown) . The levels of vib did not affect the total amount of Ataxin-1 82Q protein detected in eye imaginal discs (Supplementary Fig. S2C ). Figure 8D shows that in the HD model, OE of CG14438 (an enhancer of Htt 128Q toxicity) also increases the percentage of neurons with NIs. We could not detect alterations in NI formation with the CG14438 LOF allele. OE of vib (enhancer of Htt 128Q ) increases the percentage of neurons where Htt
128Q
NIs can be detected, and this observation was valid for both alleles. However, in the HD model OE of CHIP (a suppressor of Htt 128Q toxicity, Table 1 ) dramatically increases in the percentage of neurons containing NIs. In summary, we identified genes modifying toxicity that also alter NI formation, but we found no correlation between modification (suppression or enhancement) of the toxicity and modification (increase or decrease) in the formation of NIs.
DISCUSSION
We have used Drosophila models of SCA1 and HD for a comparative analysis of genetic factors involved in Ataxin-1 and Huntingtin-induced neurotoxicity. We found genetic modifiers flies promotes a decrease in the length of the retina compared with the phenotype of control flies (compare F with control E). Two independent OE alleles of vib were tested and the results obtain for both are identical. For simplicity only one allele is shown here. Also, the vib OE alleles do not display an eye phenotype by themselves ( Supplementary Fig. S1D , data not shown). Insets show a higher magnification view of the ommatidia and arrows indicate the length of the retina. Genotypes: (A and C) yw, UAS-SCA1 . All SCA1 82Q transgenic flies shown are 1 day old and all HD model flies are 6 days old. Flies used for SEM analysis were raised at 278C. All flies for paraffin vertical sections were raised at 258C (C-F). Scale bar in SEM pictures is equivalent to 100 mM (10 mM in the magnification insets) and equivalent to 10 mM in the retinal paraffin sections.
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Human Molecular Genetics, 2008, Vol. 17, No. 3 involved in a variety of cellular functions that affect similarly the SCA1 and HD Drosophila models. For other genes we did not detect modification of Huntingtin toxicity. Surprisingly, we also identified modifier genes that have antagonistic effects on Ataxin-1 and Huntingtin toxicity. We found no consistent correlation between modifier gene activity and NI formation.
Genes that modify the phenotypes of SCA1 and HD Drosophila models similarly Among this group of modifiers there are genes involved in protein folding, protein turnover, apoptosis and transcriptional regulation ( Table 1) . These are cellular processes that have been implicated in polyglutamine toxicity in general, and also in SCA1 82Q and Htt 128Q -induced neurodegeneration (9,25 -27) . The observation that they modulate similarly the Ataxin-1 82Q and Htt 128Q phenotypes in Drosophila provides further validation for these fly models, and suggests that novel modifiers identified in Drosophila may also be relevant to SCA1 and HD pathogenesis. Interestingly, we found specific transcription factors among the common modifiers suggesting that at least some of the genetic pathways responsible for altered transcription are common in HD and SCA1.
Other modifiers in this group are genes for which there was previously little evidence of their involvement in both OE strongly suppresses the retinal SCA1 82Q phenotype. Note the increase in the length and the improved organization of the retina (F, compare with control in E). The LOF CG14438 allele, on the other hand, aggravates the shape and organization phenotypes of ommatidia, as well as the interommatidial bristle phenotype of SCA1 82Q eyes (C, control in D). At the retinal level, CG14438
LOF reduces the length of the retina (G, control is shown in E). In contrast, OE of CG14438 in Htt 128Q flies severely reduces the length of the retina and aggravates its organization (I, control in H). Conversely, CG14438
LOF in the context of expanded Htt promotes an increase in the length of the retina along with a decrease in tissue loss (J, control in H). Both CG14438 OE and CG14438 LOF do not display an eye phenotype by themselves ( Supplementary  Fig. S1E and M) . Insets in SEM images show a higher magnification view of the ommatidia. Arrows in paraffin sections show retina's length. Genotypes: (A, D and E) yw, UAS-SCA1
82Q transgenic flies shown are 1 day old and all HD model flies are 6 days old. Flies used for SEM analysis were raised at 278C (A and B) or 258C (C and D). All flies for paraffin vertical sections were raised at 258C (E-J). Scale bar in SEM pictures is equivalent to 100 mM (10 mM in the magnification insets) and equivalent to 10 mM in the retinal paraffin sections.
Ataxin-1 82Q and Htt 128Q toxicity. These include cpo and pum, two genes encoding RNA-binding proteins. RNA-mediated mechanisms and RNA-binding proteins have been implicated in a number of neurodegenerative diseases and muscular dystrophies (3, 11) . These include disorders caused by expansion of non-translated repeats that lead (FXTAS, DM1 and DM2), or are suspected to lead (SCA8, SCA10, SCA12), to gain of RNA toxicity (28, 29) . Other neurodegenerative diseases may be caused by abnormal alternative splicing and ALS (31)], or by mutations in factors involved in splicing or mRNA localization [SMA (32) ]. We reported that RNA-binding proteins form a functional class among the Ataxin-1 genetic modifiers (18) . In addition, Ataxin-1 itself was later shown to have RNA-binding activity in vitro (33) , and whether other polyglutamine diseases besides SCA1 implicate RNA-mediated mechanisms remains unclear. In the case of pum, we find that more pum correlates with more Ataxin-1 in eye imaginal discs, which suggests that pum may promote the translation of SCA1 mRNA or cause the stabilization of Ataxin-1 82Q . Our data provides strong support for the hypothesis that RNA-binding proteins also have a role in Htt
128Q
-induced neurodegeneration, and suggests that abnormal RNA-processing may be a more general pathogenic mechanism in neurodegenerative disorders than previously anticipated.
Two other genes not previously known to modify Ataxin-1 82Q and Htt 128Q toxicity in a similar manner are 14-3-31 and RhoGAPp190, both of which participate in a variety of signal transduction pathways. RhoGAP proteins mediate growth factor dependent regulation of GTPases (34) , and have been implicated in cytoskeletal reorganization and axonal growth (35). 14-3-3 proteins are involved in many cellular processes, and they are binding partners of a large number of phosphoproteins (36) . We found that loss-of-function of 14-3-31 suppresses, and OE enhances, both Ataxin-1 82Q and Htt 128Q toxicity. In the case of Ataxin-1 82Q we understand the mechanism behind these modifications. Upon phosphorylation of Ataxin-1 82Q by Akt, 14-3-31 binds and stabilizes the phosphorylated protein, which leads to its accumulation and neurotoxic effects (19) . In the case of Htt 128Q the mechanism of modification is less clear. We expect, however, that it is different from the Ataxin-1 82Q mechanism because Akt has a protective role in Htt-induced neurodegeneration [(20) and this report]. 14-3-3 proteins co-localize with Huntingtin perinuclear inclusions in cell culture (37) , and interact with HAP-1, a protein involved in intracellular trafficking (38) . Thus, 14-3-31 may modify Htt 128Q toxicity by modulating the trafficking impairments caused by this expanded protein.
Genes that modify the phenotypes of SCA1 but not HD Drosophila models These are Ataxin-1 82Q modifier genes that do not alter Htt
-induced toxicity in our assays and experimental conditions. They include genes in some of the functional categories discussed above (Table 2) . Although negative results are difficult to interpret, some of these genes may account for differences between SCA1 82Q and Htt 128Q -induced toxicity. 82Q flies (nerv.lacZ; SCA1 82Q ) behave normally in this assay early in life, but their motor performance is impaired prematurely when compared with controls (nerv.lacZ). Note that 50% of controls still climb normally at day 30-32, Modifier genes that have antagonistic effects on the phenotypes of SCA1 and HD models Surprisingly, we found modifier genes that are common to both disease models but have antagonistic effects on SCA1 82Q and Htt 128Q -induced toxicity (Table 3) . Of all the genes in this group, the best understood is Akt. As described above, Akt phosphorylates Ataxin-1 promoting binding of 14-3-3 proteins. This leads to increased Ataxin-1 stability and thus causes neuronal degeneration (19) . Huntingtin is also a substrate of Akt, and phosphorylation of Htt at Ser421 is crucial for neuroprotection mediated by the insulinlike growth factor-1 (IGF-1) signaling pathway (20, 39) . Akt also protects from Htt toxicity by phosphorylating Arfaptin 2 and promoting proteasome function (40) . Interestingly, we (Fig. 4) . These results were reproduced independently in a motor performance assay indicating that these interactions are not specific to the eye, and confirming their relevance to neurons (Fig. 7) . These observations further suggest that RNA-mediated mechanisms are relevant to Huntingtin neurotoxicity.
OE of vib suppresses SCA1
82Q
and enhances Htt 128Q -induced toxicity, both in the eye and motor performance assays (Fig. 5) . vib encodes a conserved phospholipid transporter, which are proteins involved in lipid metabolism and membrane trafficking, and implicated in numerous cellsignaling pathways (42) . Accumulating evidence suggests that the metabolism of phospholipids in neural membranes is abnormal in neurodegenerative diseases, such as Friedreich ataxia (43) and Alzheimer's Disease (44) . Less evidence is available for the involvement of phospholipid metabolism and signaling in HD, and particularly in SCA1. However, Huntingtin has been implicated in membrane trafficking (45, 46) . Also, it has been suggested that electrostatic interactions with acidic phospholipids mediate binding of Huntingtin to membranes (47) . The genetic interactions between vib and Ataxin-1 82Q and Htt 128Q suggest that abnormal phospholipid metabolism may be a mechanism of pathogenesis also in polyglutamine diseases.
OE of CG14438 suppresses Ataxin-1 82Q and enhances Htt 128Q eye phenotypes; conversely its LOF enhances the Ataxin-1 82Q and suppresses the Htt 128Q phenotypes (Fig. 6 ). CG14438 is an uncharacterized gene encoding a long protein (3321 amino acids). It contains 21 C2H2-type zinc-fingers, which are domains that can mediate interactions to DNA, RNA or other proteins. The unknown function of this Drosophila gene provides little insight into possible mechanisms by which it may modulate SCA1 82Q and Htt
128Q
-induced toxicity. However, we find that suppression by CG14438 OE correlates with increased Ataxin-1 82Q protein levels ( Supplementary Fig. S2 ) and more NIs in SCA1 82Q flies (Fig. 8) -induced toxicity. These results are consistent with the idea that some modifiers may function by reducing the levels of mutant protein, while others function downstream of protein synthesis/clearance. Thus, our results suggest that NI formation is not a good read-out of polyglutamine-induced neuronal toxicity, and argue for caution when interpreting results from chemical screens in which the screening assay is based on aggregation of the mutant protein.
In summary, this comparative study of SCA1 and HD models in Drosophila has lead to identifying novel modifier genes that fall in two important categories. Those modifying SCA1
82Q and Htt 128Q -induced neurotoxicity in a similar manner point to new potential therapeutic targets that may be common to both diseases. A second class of modifiers genes have antagonistic effects on SCA1
82Q
and Htt
128Q
-induced toxicity, and point to disease-specific mechanisms of pathogenesis.
MATERIALS AND METHODS
Fly strains and constructs
SCA1
82Q and SCA1 30Q lines were previously described (18) . Htt 128Q flies were generated by sub-cloning a portion of N-terminal of the human Huntingtin protein (amino acids 1-336, including 128 glutamine repeats) into the Drosophila transformation vector pUAST (48) . Transgenic flies were obtained following standard procedures for embryonic germ line injection and transformation. Similar transgenes were also generated with 16 and 44 glutamines.
Flies were maintained on standard cornmeal medium. Crosses were performed at 258C or 278C in order to induce medium or high expression levels of the transgenes. In this study, the GMR-GAL4, nervana-GAL4 (both obtained from Bloomington Stock Center (Indiana University, IN, USA) and OK107-GAL4 drivers (w; FRTG13, UAS-CD8:GFP;OK107-GAL4-a gift from Dr Hugo Bellen) were used.
All stocks used were obtained from the Bloomington Stock Center with the exception of the following stocks: obtained from Exelisis (EP (2) 92E wt, UAS-14-3-31 9or and 14-3-3-1 ex4 (19); ps 3 and ps j449 were a gift from Dr Deborah Andrew (49). UAS-DIAP1 by was kindly provided by Dr Bruce Hay.
Scanning electron microscopy
Flies collected on the day of eclosion were serially dehydrated in ethanol, critical point dried, metal coated and analyzed in a Jeol JSM 6100 microscope.
Retinal paraffin sections
Adult fly heads were dissected, fixed in 4% formaldehyde overnight, dehydrated in serial dilutions of ethanol and embedded in Paraplast Plus paraffin. Ten micrometer sections were obtained using an Olympus Cut4055 microtome and afterwards re-hydrated. Sections were stained with hematoxilin (Sigma), dehydrated and mounted using Permount mounting media (Fischer Chemicals). Samples were visualized in a Nikon Microphot-FXA microscope (Nikon) and the tissue morphology was analyzed. Images were obtained using the AxionCam MRc camera from Zeiss.
Climbing assay
SCA1
82Q and Htt 128Q flies were crossed with nervana-GAL4 driver and climbing ability was analyzed throughout their lifespan. The climbing performance is determined by counting the number of flies that climb above a 5 cm line in 18 s, after being tapped to the bottom of an empty culture vial. Groups of 30 virgin female flies were kept in individual vials and their climbing performance was recorded, at least, every 2 days. A minimum of two replicas per genotype was tested.
Immunofluorescence
Adult ventral ganglions of aged flies were dissected in phosphate-buffered saline (PBS), fixed in 4% formaldehyde for 30 min and stained overnight with anti-Ataxin-1 (ata1 11NQ V, 1:750; a gift from Dr Huda Zoghbi) or antiHuntingtin (MAB5374, 1:100; Chemicon) antibodies. The secondary antibodies (anti-rabbit IgG conjugated with Cy3 and anti-mouse Texas Red, Jackson Laboratories and Molecular Probes) were used at a 1:200 dilution. Antibodies were diluted in PBS, 2% BSA. Samples were mounted using Vectashield mounting media (Vector Laboratories), visualized in a LSM510 Zeiss confocal microscope and analyzed using ImageJ software. Results from the quantifications done were calculated and plotted using Excel software and statistically analyzed by Student's t-test.
Semi-quantitative RT -PCRs
RNA from 10 eye discs/genotype was extracted using TRIzol (Invitrogen) solution and treated with DNase (Invitrogen). For the reverse transcription step, oligo-dT primers were used. For the PCR step, the primers used were: Htt 
Immunofluorescence quantification
Carried out as previously described (19) . Eye imaginal discs from age-matched larvae were stained with anti-Htt (5374 Chemicon) or anti-Ataxin-1 (11NQ). Tissue was mounted and flattened. Stacks of confocal slices were obtained through the thickness of each eye disc. Each stack was flattened and signal of the slices summed. The average intensity for each eye disc was calculated in the area with positive immunofluorescence staining (Supplemental Fig. 2 ) using Image J and the average value from four different eye discs per genotype was plotted in the chart.
